Literature DB >> 30111032

[Effect of serum containing Xihuang pill on proliferation of human breast cancer cell line MDA-MB-435 and MCF-7 Cells].

Li-Juan He1, Jin-Sheng Li2, Xia Chen2, Han-Tao Zhang2, Xiao-Guang Zhu1, Xiao-di Zhang2, Su-Hua Xie1, Hai-Ou Gu3.   

Abstract

To study the effect of serum containing Xihuang pill on the proliferation of human breast cancer cell lines MDA-MB-435 and MCF-7 and the gene and protein expressions of Bcl-2, Bax, TP53, in order to explore the effect and mechanism of Xihuang pill in resisting breast cancer. The serum of the rats was prepared by the method of MTT assay. The expressions of Bcl-2 and Bax were detected by RT-PCR. The serum levels of Bcl-2 and Bax and the mRNA expression of TP53 were detected by immunofluorescence. The rats with serum containing Xihuang pill could inhibit the proliferation of MDA-MB-435 cells and MCF-7 cells (P<0.05). The serum containing Xihuang pill increased TP53 and Bax in MDA-MB-435 cells (P<0.05), and the ratio of Bcl-2/Bax was decreased (P<0.05). Meanwhile, the serum containing Xihuang pill could up-regulate the mRNA expression of Bax in MCF-7 cells and decrease the expression of Bcl (P<0.05), but there was no significant difference between the expression of TP53mRNA and Bax protein expressions after the treatment of MCF-7 cells with Xihuang pill serum. Serum containing Xihuang pill can induce the apoptosis of human breast cancer cells, and the mechanism of estrogen receptor-negative breast cancer cell apoptosis may be induced by up-regulating the mRNA expression of TP53, which can induce the expression of Bax and promote the metastasis of Bax to mitochondria, and ultimately play the role of inducing apoptosis. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Xihuang pill ; apoptosis ; breast cancer ; drug-containing serum

Mesh:

Substances:

Year:  2018        PMID: 30111032     DOI: 10.19540/j.cnki.cjcmm.20180408.001

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology.

Authors:  Kailin Yang; Liuting Zeng; Anqi Ge; Tingting Bao; Tao Xu; Xiaobing Xie; Lifang Liu
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

2.  Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.

Authors:  Jiafa Wu; Dongping Luo; Shengnan Li
Journal:  Breast Cancer (Dove Med Press)       Date:  2020-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.